[Coronary artery aneurysms].
Explore the source record for details and available documents.
Coronary Aneurysm↗
Biomedical subjects
H Shehadeh
Publications and source records attributed to H Shehadeh.
Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.
The possible role of angiotensin-converting enzyme inhibition in preventing or minimizing tolerance to intravenous nitroglycerin in severe congestive heart failure (CHF) was studied by quantitating the degree of tolerance in 12 patients receiving nitroglycerin (group 1) and in 9 patients (group 2) receiving nitroglycerin and concurrent treatment with captopril (60 +/- 29 mg/day). At peak effect, nitroglycerin produced almost identical hemodynamic changes in both groups, with significant decreases in right atrial and pulmonary arterial wedge pressure, systolic blood pressure and systemic and pulmonary vascular resistances. Cardiac index increased. The extent of nitrate tolerance was calculated for each hemodynamic parameter as the percentage loss of the peak effect achieved by the drug. At 24 hours, 98 +/- 80% of the benefit achieved with respect to right atrial pressure was lost in group 1 and 61 +/- 74% in group 2 (group 1 vs 2, difference not significant). For pulmonary arterial wedge pressure, 51 +/- 31% (group 1) and 85 +/- 53% (group 2) (difference not significant) of the effect was lost, and for cardiac index, 53 +/- 58% (group 1) and 54 +/- 44% (group 2) (difference not significant). Tolerance was also almost identical regarding systolic blood pressure and systemic and pulmonary vascular resistance. Thus, the extent of tolerance to high-dose intravenous nitroglycerin in CHF was unaltered by administration of captopril, indicating that in clinical dosage, counter-regulatory neurohumoral mechanisms involving the renin-angiotensin system appear to be unimportant in its development.
Adult↗
[Percutaneous transluminal coronary angioplasty after coronary artery bypass].
Anginal syndrome may recur early of several years after coronary artery bypass surgery (CABS), and may be due to narrowing of a bypass graft, progression of pre-existing coronary artery lesions, or the appearance of new lesions. Repeat CABS is associated with considerable morbidity and mortality. We therefore performed percutaneous transluminal angioplasty (PTCA) in saphenous or internal mammary bypass grafts or native coronary arteries in 23 patients after CABS. We successfully dilated 35 of 37 lesions (95%) present in 33 of 35 vessels (94%) of 21 of 23 patients (91%). The mean vessel narrowing decreased from 86 +/- 22% to 13 +/- 19% (p less than 0.001) and in all 21 patients with angiographic evidence of success functional capacity improved. Single vein grafts were successfully dilated in 9 patients. None developed acute myocardial infarction or needed emergency surgery, but 1 had a cerebral embolism. PTCA is effective therapy for recurrent angina after CABS, and in many patients is preferable to another operation.
Angina Pectoris↗
Short- and long-term results of angioplasty for multiple coronary stenoses.
Sixty-eight patients underwent percutaneous transluminal coronary angioplasty (PTCA) for multiple coronary stenoses. Lesions involved one coronary vessel in 24 patients, two in 34, and three or more vessels in 10 patients. The primary patient success rate was 96%, and we successfully dilated 162 (91%) of 179 significant (i.e., greater than 70% obstructive) coronary lesions, mean 2.4 lesions/patient. Complete coronary revascularization was achieved in 24 patients (Group 1), while major narrowings were not dilated either by intention or due to failure of dilation in 42 others (Group 2). The clinical state of the patients improved markedly after successful PTCA, and 44 (72%) of 61 were in the New York Heart Association Functional Class I or II 3 to 24 months later. In keeping with the clinical results, there was a significant improvement in treadmill exercise performance, in both groups. Patients with complete revascularization, however, tended to exercise longer (NS) to a greater heart rate (P less than 0.004) with less or no ischemic ST depression on ECG (P less than 0.04). Complications were few and limited to patients undergoing PTCA for unstable angina pectoris or following acute myocardial infarction. One patient (1%) died, two (3%) had Q-wave infarction and one patient sustained a cerebral embolus during catheterization. Restenosis was observed in 6 (29%) of 21 consecutive patients recatheterized 6 to 12 months (or sooner for symptoms) after successful PTCA. Four patients underwent a repeat PTCA, one was referred for coronary artery bypass grafting (CABG), and in one restenosis was minor and symptoms were mild. PTCA should be considered in patients with multiple coronary stenoses in whom all or most of the significant lesions can be dilated. Partial revascularization by PTCA is clinically useful and may be preferable to CABG in patients in whom the surgical risk is increased.
Adult↗